Glass House Brands (GLAS) Goodwill & Intangibles (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Goodwill & Intangibles of $11.6 million for Q1 2026, down 4.08% year-over-year from $12.1 million in Q1 2025, and little changed quarter-over-quarter from $11.6 million in Q4 2025.
Glass House Brands (GLAS) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Goodwill & Intangibles for 7 consecutive years, with $11.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 4.08% year-over-year to $11.6 million; the TTM figure through Mar 2026 stood at $11.6 million (down 4.08% YoY), while the FY2025 annual figure was $11.6 million, down 18.47% from the prior year.
- Goodwill & Intangibles was little changed at $11.6 million in Q1 2026 per GLAS's latest filing, from $11.6 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $70.3 million in Q4 2022 and bottomed at $10.5 million in Q1 2022.
- Historically, Goodwill & Intangibles has averaged $28.7 million across 5 years, with a median of $20.9 million in 2024.
- On a YoY basis, Goodwill & Intangibles climbed as much as 1178.42% in 2022 and fell as far as 94.22% in 2022.
- Glass House Brands' Goodwill & Intangibles stood at $70.3 million in 2022, then slumped by 69.83% to $21.2 million in 2023, then slumped by 33.06% to $14.2 million in 2024, then fell by 18.47% to $11.6 million in 2025, then climbed by 0.42% to $11.6 million in 2026.
- Business Quant data shows GLAS's Goodwill & Intangibles at $11.6 million in Q1 2026, $11.6 million in Q4 2025, and $11.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Glass House Brands | 832.85 Mn | 814.29 Mn | 15.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.63 Mn |
| Dec 31, 2025 | 11.58 Mn |
| Sep 30, 2025 | 11.76 Mn |
| Jun 30, 2025 | 11.94 Mn |
| Mar 31, 2025 | 12.12 Mn |
| Dec 31, 2024 | 14.20 Mn |
| Sep 30, 2024 | 14.38 Mn |
| Jun 30, 2024 | 20.87 Mn |
| Mar 31, 2024 | 21.01 Mn |
| Dec 31, 2023 | 21.21 Mn |
| Sep 30, 2023 | 52.30 Mn |
| Jun 30, 2023 | 46.80 Mn |
| Mar 31, 2023 | 53.63 Mn |
| Dec 31, 2022 | 70.32 Mn |
| Sep 30, 2022 | 68.55 Mn |
| Jun 30, 2022 | 34.98 Mn |
| Mar 31, 2022 | 10.51 Mn |
| Dec 31, 2021 | 5.50 Mn |
| Sep 30, 2021 | 9.84 Mn |
| Mar 31, 2021 | 181.84 Mn |